AzTrials
AzTrials

COPDSENS4MENCT06336252

Technology Assisted Nudging to Increase Physical Activity Among Hospitalised Medical Patients

A study testing Digital nudging intervention target to change behavior in people with COPD and Heart Failure, run by Bispebjerg Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary Objective To investigate if patients hospitalised for older adults with a decreased level of physical function, either related to a chronic condition e.g., COPD, Congestive heart failure, renal failure; infections; frailty and tendency of falling; orthopaedic surgery - after hip fracture will increase their… Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
COPD, Heart Failure, Parkinson Disease
What is being tested?
Digital nudging intervention target to change behavior
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 siteDenmark
Study dates
3 May 2024to 7 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • An individual will be eligible for study participation if he/she meets the following criteria:
  • Aged ≥60
  • Is admitted to one of the participating departments
  • Has signed informed consent
  • Reads and speaks Danish, Norwegian, Italian, or English

Who cannot join

  • An individual will be excluded from the study if he/she meets any of the following criteria:
  • Any condition that, in the opinion of the investigator, makes the person unfit for participation, e.g., delirium and/or psychotic symptoms; moderate or severe depression (GDS>8 (short form)); major surgery; moderate/severe dementia (MoCA≤18); chemotherapy or radiation treatment ongoing at enrolment; moderate/severe frailty (CFS≥6)
  • Expected hospitalisation less than 24 hours
  • Has allergy towards band aid
  • Enrolled in any other clinical study within the duration of the current study.
  • While these criteria represent the criteria for being observed, only patients observed for at least 24 hours are included in the analysis population. For practical reasons it is not possible to predict those patients eligible for the analysis population at inclusion. Hence, we will monitor more patients than we will analyse (see statistical analysis section).

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Christian Dall

    Copenhagen, 2400

Other trials in Denmark

About this study

Official title: Technology Assisted Nudging to Increase Physical Activity Among Hospitalised Medical Patients in Hospital and 3 Months After Discharge

Primary Objective To investigate if patients hospitalised for older adults with a decreased level of physical function, either related to a chronic condition e.g., COPD, Congestive heart failure, renal failure; infections; frailty and tendency of falling; orthopaedic surgery - after hip fracture will increase their time spent out of bed during hospitalisation and 3 months after discharge through visual feedback and motivational intervention about physical activities from a new mobile technology.

Hypothesis Patients hospitalised for medical disease will increase their physical activity level during hospitalisation and 3 months after discharge through visual feedback and motivational intervention from a new mobile technology.

Read the detailed description

STUDY DESIGN Description of the protocol The study will be conducted as a randomised multicentre trial including 3 hospitals in Europe (Copenhagen, Stavanger, and Genova). Patients admitted to Department of Respiratory Medicine, Department of Cardiology, and Department of Geriatrics, Department of Orthopaedic disease or Department of Neurology will be included, and they will have their physical activity level measured either with or without a monitor providing visual feedback of time spent bedridden, sitting, standing, and walking. After discharge the feedback will include an ergometer bike or sofa bike connected to the feedback mechanism.

Design A randomised multicentre study design is chosen. All participants will have their physical activity measured during hospitalisation and after discharge. Approximately half of the participants will receive visual feedback about the amount of physical activity from a mobile device placed on the bedside table while hospitalized, and after discharge, they will be provided with an ergometer bike or sofa bike connected to the feedback mechanism.

Allocation of participants The allocation of participants will be done 1 to 1, stratified by age group, gender, and level of mobility, to the control group (no feedback) and intervention group (visual feedback group). We schedule, that 162 patients will be possible to include in the analysis set (54 patients are planned to be included in Denmark, Norway, and Italy). A computer-generated randomisation sequence will be used to assign the participants in each site to the intervention and control arms.

Duration of study participation Each participant will be observed from admission of hospitalisation or until he/she is discharged and followed for 3 months.

Being tested
Digital nudging intervention target to change behavior
Medical subject headings
Pulmonary Disease, Chronic Obstructive, Heart Failure, Parkinson Disease, Arthritis, Cachexia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digital nudging intervention target to change behaviorBehavioural

    In hospital Participants in the intervention group will receive usual hospital care and be provided with a sensor collecting data on physical activity level during hospitalisation AND a monitor placed at their bedside that displays information about their physical activity level, in terms of time spent bedridden, sitting, standing, and walking. This information will be visible to the health personnel, the patients, and their relatives. This feedback system is developed and provided by SENS Innovation.

    After discharge The visual feedback system from SENS will be continued after discharge and include an E-sport biking system provided by 4Mvideo. This integrated new system will combine an ergometer bike or sofa bike installed in the patient's own home or nursing home, and data from the sensor that the participants continue to wear after discharge will go into the SENS system, feeding back a visual track of their activities

Study groups in NCT06336252
Study groupRoleWhat they receive
Arm 1 digital nudgingExperimentalIn hospital Participants in the intervention group will receive usual hospital care and be provided with a sensor collecting data on physical activity level during hospitalisation AND a monitor placed at their bedside that displays information about their physical activity level, in terms of time spent bedridden, sitting, standing, and walking. This information will be visible to the health personnel, the patients, and their relatives. This feedback system is developed and provided by SENS Innovation. After discharge The visual feedback system from SENS will be continued after discharge and include an E-sport biking system provided by 4Mvideo. This integrated new system will combine an ergometer bike or sofa bike installed in the patient's own home or nursing home, and data from the sensor that the participants continue to wear after discharge will go into the SENS system, feeding back a visual track of their activities
Receives: Behavioral: Digital nudging intervention target to change behavior
Arm 2 usual careNo interventionThe participants in the non-exposed cohort will receive usual hospital care and be provided with a sensor collecting data on activity level during hospitalisation.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time spent out of bed measured in minutes related to the total accelerometer wear time (minutes)

    To assess physical activity a small tri-axial accelerometers is used. The accelerometer measures activity data in minutes per day.

    Measured: 3 month

Secondary outcomes (7)
  1. Readmission within 90 days

    Number of readmissions 90 days following discharge

    Measured: 3 month

  2. Length of stay (days)

    Days of hospitalization

    Measured: 3 month assessment

  3. Time spent lying down, sitting, standing, and walking measured in minutes related to the total accelerometer wear time (minutes)

    Measured by objective accelerometer

    Measured: 3 month

  4. Time spent out of bed in hospital in minutes related to the total accelerometer wear time (minutes)

    Measured by objective accelerometer

    Measured: 3 month assessment

  5. Time spent out of bed after discharge in minutes related to the total accelerometer wear time (minutes)

    Measured by objective accelerometer

    Measured: 3 month

  6. Quality of life (EQ5D-5L)

    PROM quality of life, increase means better quality of life score

    Measured: 3 month

  7. - In-hospital fall incidents

    Number of falls

    Measured: 3 month assessment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2024
  2. Study start3 May 2024
  3. Primary completion7 Jun 2025
  4. Study completion7 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
1/1 allocation
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06336252
Sponsor's protocol ID
F-23059441
Acronym
SENS4ME
Status last verified
Jul 2026
First submitted
13 Mar 2024
Last updated
7 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Due to Danish legislation

Questions about this trial

What is this clinical trial studying?

A study testing Digital nudging intervention target to change behavior in people with COPD and Heart Failure, run by Bispebjerg Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time spent out of bed measured in minutes related to the total accelerometer wear time (minutes) (time frame: 3 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in